Self-Amplifying RNA Synthesis Market
完整報告名稱與涵蓋範圍
Self-Amplifying RNA Synthesis Market Size, Share & Trends Analysis By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), by Region, And by Segment Forecasts, 2025-2034
報告摘要
The worldwide Self-Amplifying RNA Synthesis Market stood at USD 115.1 Mn in 2024, and is poised to reach USD 715.6 Mn by 2034, recording a CAGR of 20.4% from 2025 through 2034.
Self-Amplifying RNA Synthesis covers reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Self-amplifying RNA Synthesis Market Snapshot
Chapter 4. Global Self-amplifying RNA Synthesis Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Self-amplifying RNA Synthesis Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on Self-amplifying RNA Synthesis Market Industry Trends
Chapter 5. Self-amplifying RNA Synthesis Market Segmentation 1: By Product & Service, Estimates & Trend Analysis
5.1. Market Share by Product & Service, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product & Service:
5.2.1. Products
5.2.1.1. Premade saRNA
5.2.1.2. Enzymes & Reagents
5.2.1.3. Others
5.2.2. Custom Synthesis Services
Chapter 6. Self-amplifying RNA Synthesis Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Therapeutics Development
6.2.1.1. Infectious Diseases
6.2.1.2. Oncology
6.2.1.3. Others
6.2.2. Biomedical Research
Chapter 7. Self-amplifying RNA Synthesis Market Segmentation 3: By End Use, Estimates & Trend Analysis
7.1. Market Share by End Use, 2024 & 2034
7.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End Use:
7.2.1. Pharmaceutical & Biotechnology Companies
7.2.2. Academic & Research Institutes
7.2.3. Other End Use
Chapter 8. Self-amplifying RNA Synthesis Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Self-amplifying RNA Synthesis Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Product & Service, 2021-2034
8.2.3. North America Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by End Use, 2021-2034
8.3. Europe
8.3.1. Europe Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Product & Service, 2021-2034
8.3.3. Europe Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by End Use, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Product & Service, 2021-2034
8.4.3. Asia Pacific Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by End Use, 2021-2034
8.5. Latin America
8.5.1. Latin America Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Product & Service, 2021-2034
8.5.3. Latin America Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by End Use, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Product & Service, 2021-2034
8.6.3. Middle East & Africa Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa Self-amplifying RNA Synthesis Market Revenue (US$ Mn) Estimates and Forecasts by End Use, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. GenScript
9.2.1.1. Business Overview
9.2.1.2. Key Product & Service/Service
9.2.1.3. Financial PerApplicationance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Creative Biogene.
9.2.3. OZ Biosciences
9.2.4. BOC Sciences
9.2.5. Croyez Bioscience Co., Ltd.
9.2.6. Creative Biolabs.
9.2.7. Maravai LifeSciences
9.2.8. Areterna LLC
9.2.9. Applied DNA Sciences, Inc. (LineaRx)
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們